CASI PHARMACEUTICALS INC - COM (CASI)

CUSIP: 14757U109

Q1 2017 13F Holders as of 31 Mar 2017

Type / Class
Equity / COM
Total 13F shares
2,341,993
Share change
+399,489
Total reported value
$3,324,000
Price per share
$1.42
Number of holders
17
Value change
+$578,948
Number of buys
5
Number of sells
7

Quarterly Holders Quick Answers

What is CUSIP 14757U109?
CUSIP 14757U109 identifies CASI - CASI PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CASI PHARMACEUTICALS INC - COM (CASI) as of Q1 2017

As of 31 Mar 2017, CASI PHARMACEUTICALS INC - COM (CASI) was held by 17 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,341,993 shares. The largest 10 holders included Wellington Shields Capital Management, LLC, Wellington Shields & Co., LLC, VANGUARD GROUP INC, BlackRock Inc., CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, RENAISSANCE TECHNOLOGIES LLC, Raymond James Financial Services Advisors, Inc., GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, and KCG HOLDINGS, INC.. This page lists 17 institutional shareholders reporting positions in this security for the Q1 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.